Our gene therapy and regenerative medicine funded research

Gene therapy and regenerative medicine therapy (stem cells) are already providing much hope in other fields of medicine. We wish to continue to invest in these areas so that new treatments can be made available across a range of blinding eye conditions, from glaucoma to macular degeneration, to inherited eye conditions. 

You can read below about our current funded research in these areas, including a study to gain better understanding of how patients with genetic eye conditions can access genetic counselling more effectively, and how gene therapy's success can be supported by switching off the body's own inflammation response.